KVA12123

· Kineta Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KVA12123, covering 2023-07-13 to 2023-07-13. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]

See pricing